Suppr超能文献

开发集成电子用药核对平台及其对预防潜在重复用药和降低住院患者 30 天内药物相关再入院的效果评估。

Developing an Integrated Electronic Medication Reconciliation Platform and Evaluating its Effects on Preventing Potential Duplicated Medications and Reducing 30-Day Medication-Related Hospital Revisits for Inpatients.

机构信息

Department of Pharmacy, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1st Road, Zuoying District, Kaohsiung City, 81362, Taiwan.

Department of Pharmacy, School of Pharmacy, Kaohsiung Medical University, No.100, Shih-Chuan 1st Road, Sanmin Dist, Kaohsiung City, 80708, Taiwan.

出版信息

J Med Syst. 2021 Mar 1;45(4):47. doi: 10.1007/s10916-021-01717-8.

Abstract

The aims were to develop an integrated electronic medication reconciliation (ieMR) platform, evaluate its effects on preventing potential duplicated medications, analyze the distribution of the potential duplicated medications by the Anatomical Therapeutic and Chemical (ATC) code for all inpatients, and determine the rate of 30-day medication-related hospital revisits for a geriatric unit. The study was conducted in a tertiary medical center in Taiwan and involved a retrospective quasi pre-intervention (July 1-November 30, 2015) and post-intervention (October 1-December 31, 2016) study design. A multidisciplinary team developed the ieMR platform covering the process from admission to discharge. The ieMR platform included six modules of an enhanced computer physician order entry system (eCPOE), Pharmaceutical-care, Holistic Care, Bedside Display, Personalized Best Possible Medication Discharge Plan, and Pharmaceutical Care Registration System. The ieMR platform prevented the number of potential duplicated medications from pre (25,196 medications, 2.3%) to post (23,413 medications, 3.8%) phases (OR 1.71, 95% CI, 1.68-1.74; p < .001). The most common potential duplicated medications classified by the ATC codes were cardiovascular system (28.4%), alimentary tract and metabolism (26.4%), and nervous system (14.9%), and by chemical substances were sennoside (12.5%), amlodipine (7.5%), and alprazolam (7.4%). The rate of medication-related 30-day hospital revisits for the geriatric unit was significantly decreased in post-intervention compared with that in pre-intervention (OR = 0.12; 95% CI, 0.03-0.53; p < .01). This study indicated that the ieMR platform significantly prevented the number of potential duplicated medications for inpatients and reduced the rate of 30-day medication-related hospital revisits for the patients on the geriatric unit.

摘要

目的是开发一个集成的电子用药医嘱核对(ieMR)平台,评估其在预防潜在重复用药方面的效果,分析所有住院患者按解剖治疗化学(ATC)代码分布的潜在重复用药情况,并确定老年病房 30 天内与药物相关的医院复诊率。该研究在台湾的一家三级医疗中心进行,采用回顾性准干预(2015 年 7 月 1 日至 11 月 30 日)和干预后(2016 年 10 月 1 日至 12 月 31 日)研究设计。一个多学科团队开发了涵盖从入院到出院过程的 ieMR 平台。ieMR 平台包括增强型计算机医嘱输入系统(eCPOE)、药学护理、整体护理、床边显示、个性化最佳可能用药出院计划和药学护理登记系统六个模块。ieMR 平台防止了潜在重复用药的数量从预(25196 种药物,2.3%)到后(23413 种药物,3.8%)阶段增加(OR 1.71,95%CI,1.68-1.74;p<.001)。按 ATC 代码分类的最常见潜在重复用药为心血管系统(28.4%)、消化道和代谢(26.4%)和神经系统(14.9%),按化学物质分类为番泻苷(12.5%)、氨氯地平(7.5%)和阿普唑仑(7.4%)。老年病房与药物相关的 30 天内医院复诊率在干预后明显低于干预前(OR=0.12;95%CI,0.03-0.53;p<.01)。本研究表明,ieMR 平台显著减少了住院患者潜在重复用药的数量,并降低了老年病房患者 30 天内与药物相关的医院复诊率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验